Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance

Efficacy of metreleptin treatment in familial partial lipodystrophy due to PPARG versus LMNA pathogenic variants

(2019) Hilal Sekizkardes et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comorbidities and Survival in Patients with Lipodystrophy: An International Chart Review Study

(2019) Baris Akinci et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy

(2018) Rebecca J. Brown et al.   JOURNAL OF CLINICAL INVESTIGATION

Beneficial effects of leptin substitution on impaired eating behavior in lipodystrophy are sustained beyond 150 weeks of treatment

(2018) Janett Püschel et al.   CYTOKINE

Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease

(2018) Iram Hussain et al.   PATHOLOGY

Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy

(2017) Baris Akinci et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Leptin Substitution in Patients With Lipodystrophy: Neural Correlates for Long-term Success in the Normalization of Eating Behavior

(2016) Haiko Schlögl et al.   DIABETES

The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline

(2016) Rebecca J. Brown et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin

(2015) Talia Diker-Cohen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Congenital generalized lipodystrophies—new insights into metabolic dysfunction

(2015) Nivedita Patni et al.   Nature Reviews Endocrinology

The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis

(2015) Chiara Saponaro et al.   Nutrients

Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women

(2015) Leanne Hodson et al.   Journal of the American Heart Association

The Clinical Approach to the Detection of Lipodystrophy – An AACE Consensus Statement

(2015) Yehuda Handelsman et al.   Endocrine Practice

Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency

(2012) Philippe M. Campeau et al.   JOURNAL OF LIPID RESEARCH

Efficacy of leptin therapy in the different forms of human lipodystrophy

(2009) A. Y. Chong et al.   DIABETOLOGIA

Fatty Acid Metabolism in Patients with PPARγ Mutations

(2008) Garry D. Tan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Leptin therapy for partial lipodystrophy linked to a PPAR-γ mutation

(2007) Jean-Marc Guettier et al.   CLINICAL ENDOCRINOLOGY